297
Views
21
CrossRef citations to date
0
Altmetric
Original Articles

ESI-MS and MS/MS identification of the first ceramide analogues of fumonisin B1 mycotoxin from a Fusarium verticillioides culture following RP-HPLC separation

, , , &
Pages 1651-1659 | Received 06 Mar 2013, Accepted 26 May 2013, Published online: 10 Jul 2013

References

  • Bartók T, Szécsi Á, Szekeres A, Mesterházy Á, Bartók M. 2006. Detection of new fumonisin mycotoxins and fumonisin-like compounds by reversed-phase high-performance liquid chromatography/electrospray ionization ion trap mass spectrometry. Rapid Commun Mass Spectrom. 20: 2447–2462.
  • Bartók T, Szekeres A, Szécsi Á, Bartók M, Mesterházy Á. 2008. A new type of fumonisin series appeared on the scene of food and feed safety. Cereal Res Commun Suppl B. 36:315–319.
  • Bartók T, Tölgyesi L, Mesterházy Á, Bartók M, Szécsi Á. 2010. Identification of the first fumonisin mycotoxins with three acyl groups by ESI-ITMS and ESI-TOFMS following RP-HPLC separation: palmitoyl, linoleoyl and oleoyl EFB1 fumonisin isomers from a solid culture of Fusarium verticillioides. Food Addit Contam. 27:1714–1723.
  • Bartók T, Tölgyesi L, Szécsi Á, Varga J, Bartók M, Mesterházy Á, Gyimes E, Véha A. 2013. Identification of unknown isomers of fumonisin B5 mycotoxin in a Fusarium verticillioides culture by high-performance liquid chromatography/electrospray ionization time-of-flight and ion trap mass spectrometry. J Liq Chromatogr Relat Technol. 36:1549–1561.
  • Bartók T, Tölgyesi L, Szekeres A, Varga M, Bartha R, Szécsi Á, Bartók M, Mesterházy Á. 2010. Detection and characterization of twenty-eight isomers of fumonisin B1 (FB1) mycotoxin in a solid rice culture infected with Fusarium verticillioides by reversed-phase high-performance liquid chromatography/electrospray ionization time-of-flight and ion trap mass spectrometry. Rapid Commun Mass Spectrom. 24:35–42.
  • Desai K, Sullards MC, Allegood J, Wang E, Schmelz EM, Hartl M, Humpf H-U, Liotta DC, Peng Q, Merrill Jr AH. 2002. Fumonisins and fumonisin analogs as inhibitors of ceramide synthase and inducers of apoptosis. Biochim Biophys Acta-Mol Cell Biol Lipids. 1585:188–192.
  • Du L, Zhu X, Gerber R, Huffman J, Lou L, Jorgenson J, Yu F, Zaleta-Rivera K, Wang Q. 2008. Biosynthesis of sphinganine-analog mycotoxins. J Ind Microbiol Biotechnol. 35:455–464.
  • Gelderblom WCA, Sewram V, Shephard GS, Snijman PW, Tenza K, Van Der Westhuizen L, Vleggaar R. 2007. Structure and natural occurrence of stereoisomers of the fumonisin B series mycotoxins. J Agric Food Chem. 55:4388–4394.
  • Groesch S, Schiffmann S, Geisslinger G. 2012. Chain length-specific properties of ceramides. Prog Lipid Res. 51:50–62.
  • Harrer H, Laviad LA, Humpf H-U, Futerman AH. 2013. Identification of N-acyl-fumonisin B1 as new cytotoxic metabolites. Mol Nutr Food Res. 57:516–522.
  • Humpf H-U, Schmelz E-M, Meredith FI, Vesper H, Vales TR, Wang E, Menaldino DS, Liotta DC, Merrill Jr AH. 1998. Acylation of naturally occurring and synthetic deoxysphinganines by ceramide synthase. Formation of N-palmitoyl-aminopentol produces a toxic metabolite of hydrolyzed fumonisin, AP1, and a new category of ceramide synthase inhibitor. J Biol Chem. 273:19060–19084.
  • Mansson M, Klejnstrup ML, Phipps RK, Nielsen KF, Frisvad JC, Gotfredsen CH, Larsen TO. 2010. Isolation and NMR characterization of fumonisin B2 and a new fumonisin B6 from Aspergillus niger. J Agric Food Chem. 58:949–953.
  • Marasas WFO, Riley RT, Hendricks KA, Stevens V, Sadler TW, Gelineau-van Waes J, Missmer SA, Cabrera J, Torres O, Gelderblom WCA, et al. 2004. Fumonisins disrupt sphingolipid metabolism, folate transport, and neural tube development in embryo culture and in vivo: a potential risk factor for human neural tube defects among populations consuming fumonisin-contaminated maize. J Nutr. 134:711–716.
  • Merrill AH. 2002. De novo sphingolipid biosynthesis: a necessary, but dangerous, pathway. J Biol Chem. 277:25843–25846.
  • Norred WP, Riley RT, Meredith FI, Poling SM, Plattner RD. 2001. Instability of N-acetylated fumonisin B1 (FA1) and the impact on inhibition of ceramide synthase in rat liver slices. Food Chem Toxicol. 39:1071–1078.
  • Rheeder JP, Marasas WFO, Vismer HF. 2002. Production of fumonisin analogs by Fusarium species. Appl Environ Microbiol. 68:2101–2105.
  • Seefelder W, Schwerdt G, Freudinger R, Gekle M, Humpf H-U. 2002. Liquid chromatography/electrospray ionisation-mass spectrometry method for the quantification of sphingosine and sphinganine in cell cultures exposed to fumonisins. J Chromatogr B. 780:137–144.
  • Seiferlein M, Humpf H-U, Voss KA, Sullards MC, Allegood JC, Wang E, Merrill AH. 2007. Hydrolyzed fumonisins HFB1 and HFB2 are acylated in vitro and in vivo by ceramide synthase to form cytotoxic N-acyl-metabolites. Mol Nutr Food Res. 51:1120–1130.
  • Stockmann-Juvala H, Savolainen K. 2008. A review of the toxic effects and mechanisms of action of fumonisin B1. Hum Exp Toxicol. 27:799–809.
  • Voss KA, Smith GW, Haschek WM. 2007. Fumonisins: toxicokinetics, mechanism of action and toxicity. Animal Feed Sci Technol. 137:299–325.
  • Wang E, Norred WP, Bacon CW, Riley RT, Merrill Jr AH. 1991. Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniliforme. J Biol Chem. 266:14486–14490.
  • Zitomer NC, Mitchell T, Voss KA, Bondy GS, Pruett ST, Garnier-Amblard EC, Liebeskind LS, Park H, Wang E, Sullards MC, et al. 2009. Ceramide synthase inhibition by fumonisin B-1 causes accumulation of 1-deoxysphinganine. J Biol Chem. 284:4786–4795.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.